BeyondSpring (BYSI) Net Shares Issued and Repurchased (2020 - 2026)
BeyondSpring's (BYSI) quarterly Net Shares Issued and Repurchased came in at $183624.0 in Q2 2026, down 18.3% year-over-year from $224750.0 in Q2 2025, and down 71.36% quarter-over-quarter from $641249.0 in Q1 2026.
Analysis
BeyondSpring (BYSI) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
BeyondSpring has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $183624.0 for Q2 2026.
- In Q2 2026, Net Shares Issued and Repurchased fell 18.3% year-over-year to $183624.0; the TTM figure through Jun 2026 stood at $183624.0 (down 18.3% YoY), while the FY2025 annual figure was $375344.0, down 42.37% from the prior year.
- Net Shares Issued and Repurchased came in at $183624.0 for Q2 2026 at BeyondSpring, down from $641249.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.3 million in Q4 2022 to a low of $4500.0 in Q1 2025.
- Average Net Shares Issued and Repurchased over 4 years is $480257.1, with a median of $375344.0 recorded in 2025.
- Year-over-year, Net Shares Issued and Repurchased sank 42.37% in 2025 and surged 14149.98% in 2026.
- Over 4 years, Net Shares Issued and Repurchased stood at $1.3 million in 2022, then sank by 49.15% to $651333.0 in 2024, then slumped by 42.37% to $375344.0 in 2025, then sank by 51.08% to $183624.0 in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $183624.0 in Q2 2026, $641249.0 in Q1 2026, and $375344.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 183,624.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 183,624.00 |
| Mar 31, 2026 | 641,249.00 |
| Dec 31, 2025 | 375,344.00 |
| Jun 30, 2025 | 224,750.00 |
| Mar 31, 2025 | 4,500.00 |
| Dec 31, 2024 | 651,333.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 801,291.00 |
| Mar 31, 2020 | 381,301.00 |